Skip to main content
Triochem Products Ltd. logo

Triochem Products Ltd. — Investor Relations & Filings

Ticker · 512101 ISIN · INE331E01013 BSE.NS Manufacturing
Open in API
Filings indexed 442 across all filing types
Latest filing 2020-07-28 Regulatory Filings
Country IN India
Listing BSE.NS 512101

About Triochem Products Ltd.

https://www.triochemproducts.com

Triochem Products Ltd. is a manufacturer and exporter specializing in Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. The company focuses on the production of high-quality chemical compounds for the global healthcare and pharmaceutical sectors. Its core product portfolio includes a range of specialized substances such as Quinine salts, Quinidine salts, and other niche therapeutic ingredients. Triochem Products Ltd. emphasizes adherence to stringent quality control measures and international regulatory standards to ensure the efficacy and safety of its chemical outputs. The organization serves a diverse clientele, providing essential raw materials for the formulation of various medications. By leveraging advanced chemical synthesis processes and technical expertise, the company maintains a significant presence in the supply chain for specialized pharmaceutical components.

Recent filings

Filing Released Lang Actions
With reference to your email dated 27th July 2020 for discrepancy in Corporate Governance Report (Regulation 27(2) of SEBI (LODR) Regulations 2015) submitted for the Quarter ended June 2020..... ....
Regulatory Filings
2020-07-28 English
We are enclosing herewith the confirmation certificate dated 10th July 2020 received from M/s. Sharex Dynamic (India) Pvt. Ltd., Registrar and Share Transfer Agent (RTA) of our Company ....
Regulatory Filings
2020-07-12 English
Pursuant to Clause 4 of Schedule B read with Regulation 9 of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation, 2015 as amended from time to time read with ....
Regulatory Filings
2020-07-05 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Corporate Relationship Department of BSE Limited, referencing a SEBI circular about fund raising by issuance of debt securities by large entities. The company confirms that it is not classified as a Large Corporate Entity and therefore is not required to file the initial disclosure for the quarter ended June 30, 2020. The document is a regulatory compliance statement or confirmation rather than a financial report or detailed filing. It is short (1632 characters) and serves as a notification or confirmation to the regulator. It does not contain financial data, audit information, or detailed report content. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements and compliance documents that do not fit other specific categories.
2020-07-05 English
Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount for unlisted debt securities i.e. NCDs and NCRPS
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Corporate Relationship Department of BSE Limited, submitting a statement of defaults on payment of interest/repayment of principal amount on loans and unlisted debt securities as per SEBI (Listing Obligation & Disclosures Requirement) Regulation, 2015. It provides specific financial data about defaults (all nil) for the quarter ended 30th June 2020. The document is short (2257 characters) and is a regulatory compliance submission rather than a full financial report or announcement. It does not contain comprehensive financial statements or detailed analysis, nor is it an announcement of a report publication. It is a regulatory filing to comply with SEBI disclosure requirements regarding defaults on debt payments. Therefore, it fits best under Regulatory Filings (RNS).
2020-07-05 English
Disclosures by listed entities of defaults on payment of interest/ repayment of principal amount for loans including revolving facilities like cash credit from banks ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the Corporate Relationship Department of BSE Limited, submitting a statement of defaults on payment of interest/repayment of principal amount on loans and unlisted debt securities as per SEBI (Listing Obligation & Disclosures Requirement) Regulation, 2015. It covers the quarter ended 30th June 2020 and references a BSE circular. The document is short (2257 characters), contains no financial statements or detailed financial analysis, and is essentially a regulatory compliance disclosure about defaults (or lack thereof). It is not a full financial report, audit report, or earnings release. It is a regulatory announcement related to compliance with listing obligations. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-07-05 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.